Biomarker | Sample | Method | Normal range | Range in TBI |
---|---|---|---|---|
S100β | Serum | IC | <0.11 µg/l | >0.11 µg/la |
NSE | Serum | Immunodetection based on ECL | From <17 to <25 µg/l, depending on age | >20 µg/la |
CSF | Immunodetection based on ECL | <15 µg/l | 54.80 ± 43.34 µg/lb | |
P-tau | CSF | ELISA | <70 pg/ml | N/A |
Tau | CSF | ELISA | <400 pg/ml | 1684–8691 pg/mlc |
Aβ-42 | CSF | ELISA | >500 pg/ml | <230 pg/mld
<350 pg/mle |
IL-6 | Plasma | IC | <5.9 ng/l | N/A |
IL-8 | Plasma | IC | <62 ng/l | N/A |
TNF-α | Serum | IC | <8.1 ng/l | N/A |
The assays shown in the table respond to the head injuries and to the conditions of the central nervous system, but only S100β has TBI as the main indication. The data were collected from the laboratory manuals of large hospitals in September 2016. IC, immunochemiluminescence; ECL, electrochemiluminescence; Aβ-42, amyloid-beta-42 protein. aReference values defined in clinical laboratories. bBrandner et al. (2013). cMagnoni et al.(2012). dFranz et al. (2003). eMondello et al.(2014).